PubRank

Naoshi Nishida

Author PubWeight™ 34.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2009 2.57
2 Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Gastroenterology 2008 1.43
3 Heat shock protein A4 controls cell migration and gastric ulcer healing. Dig Dis Sci 2015 1.42
4 Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. Int J Cancer 2008 1.15
5 Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut 2010 1.05
6 Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology 2013 0.98
7 General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan. Dig Dis 2015 0.96
8 Validation of the criteria of transcatheter arterial chemoembolization failure or refractoriness in patients with advanced hepatocellular carcinoma proposed by the LCSGJ. Oncology 2014 0.95
9 Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology 2014 0.94
10 Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma. J Gastroenterol 2014 0.93
11 Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas. J Gastroenterol 2004 0.91
12 Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar. AJR Am J Roentgenol 2002 0.91
13 Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma. Oncology 2015 0.90
14 Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis. Genes Chromosomes Cancer 2005 0.90
15 Cold-inducible RNA-binding protein promotes the development of liver cancer. Cancer Sci 2015 0.89
16 Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria). Dig Dis 2015 0.89
17 Real-Life Clinical Practice with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Center Experience Second Analysis. Dig Dis 2015 0.89
18 Impact of peginterferon alpha-2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B. J Med Virol 2013 0.86
19 Transcatheter arterial embolization for tumor seeding in the chest wall after radiofrequency ablation for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2006 0.85
20 Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss. Genes Chromosomes Cancer 2002 0.82
21 Hypothermia protects against fulminant hepatitis in mice by reducing reactive oxygen species production. Dig Dis 2013 0.81
22 Association of gankyrin and stemness factor expression in human colorectal cancer. Dig Dis Sci 2013 0.80
23 Validation of Kinki Criteria, a Modified Substaging System, in Patients with Intermediate Stage Hepatocellular Carcinoma. Dig Dis 2016 0.80
24 Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses. Cancer Genet Cytogenet 2006 0.80
25 Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence. Dig Dis 2014 0.80
26 Duration of stable disease is associated with overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib. Dig Dis 2014 0.79
27 Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study. J Gastroenterol 2013 0.79
28 Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience. Oncology 2015 0.79
29 Expression of E-cadherin and vascular endothelial growth factor in noncancerous liver is associated with recurrence of hepatocellular carcinoma after curative resection. Oncology 2013 0.78
30 Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma. Oncology 2015 0.78
31 Advanced hepatocellular carcinoma with lymph node metastases showing epithelial to mesenchymal transition effectively treated with systemic chemotherapy: Report of a case. Hepatol Res 2013 0.78
32 US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases. Dig Dis 2016 0.77
33 Genome-wide microsatellite analysis of focal nodular hyperplasia: a strong tool for the differential diagnosis of non-neoplastic liver nodule from hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2006 0.77
34 Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection. Intern Med 2012 0.77
35 Heat shock protein 27 expression is inversely correlated with atrophic gastritis and intraepithelial neoplasia. Dig Dis Sci 2012 0.77
36 Characteristic pattern of reactivation of hepatitis B virus during chemotherapy for solid cancers. Dig Dis 2012 0.77
37 Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer. Inflamm Bowel Dis 2017 0.77
38 Clinical Significance of Epigenetic Alterations in Human Hepatocellular Carcinoma and Its Association with Genetic Mutations. Dig Dis 2016 0.76
39 The prognostic value of vascular endothelial growth factor in hepatocellular carcinoma for predicting metastasis after curative resection. Oncology 2013 0.76
40 A Newly Developed Shear Wave Elastography Modality: With a Unique Reliability Index. Oncology 2015 0.76
41 Decreased blood flow after sorafenib administration is an imaging biomarker to predict overall survival in patients with advanced hepatocellular carcinoma. Dig Dis 2014 0.76
42 Involvement of heat shock protein a4/apg-2 in refractory inflammatory bowel disease. Inflamm Bowel Dis 2015 0.75
43 Cases with Refractory Ascites and a Delayed Response to Tolvaptan. Intern Med 2016 0.75
44 Malignant Transformation of Hepatocellular Adenoma. Oncology 2016 0.75
45 Influence of Liver Inflammation on Liver Stiffness Measurement in Patients with Autoimmune Hepatitis Evaluation by Combinational Elastography. Oncology 2017 0.75
46 Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2. Dig Dis 2017 0.75
47 Outcome of Asunaprevir/Daclatasvir Combination Therapy for Chronic Liver Disease Type C. Dig Dis 2016 0.75
48 Prospective Risk Analysis of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C by Ultrasound Strain Elastography. Dig Dis 2016 0.75
49 Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals. Dig Dis 2017 0.75
50 Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer. Inflamm Bowel Dis 2016 0.75
51 Genotype stability and clonal evolution of hepatocellular carcinoma assessed by autopsy-based genome-wide microsatellite analysis. Cancer Genet Cytogenet 2005 0.75
52 Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver Cirrhosis. Dig Dis 2016 0.75
53 Cone-Beam CT Angiography for Hepatocellular Carcinoma: Current Status. Dig Dis 2015 0.75
54 Challenges of Clinical Research on Hepatocellular Carcinoma. Dig Dis 2015 0.75
55 Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease. Oncology 2016 0.75
56 Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience. Dig Dis 2017 0.75
57 Ultrasound elastography correlates treatment response by antiviral therapy in patients with chronic hepatitis C. Oncology 2014 0.75
58 Contrast-Enhanced Tissue Harmonic Imaging versus Phase Inversion Harmonic Sonographic Imaging for the Delineation of Hepatocellular Carcinomas. Oncology 2016 0.75
59 Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2. Dig Dis 2016 0.75
60 Hepatocarcinogenesis Is Associated with Serum Albumin Levels after Sustained Virological Responses with Interferon-Based Therapy in Patients with Hepatitis C. Dig Dis 2017 0.75
61 Risk of hepatocellular carcinoma development in cases of hepatitis C treated by long-term, low-dose PEG-IFNα-2a. Dig Dis 2012 0.75
62 Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection. Dig Dis 2017 0.75
63 Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma. Dig Dis 2016 0.75
64 Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2. Dig Dis 2017 0.75